Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour

Losartan potassium is an angiotensin II receptor antagonist readily absorbed from the GIT, following oral administration. It has low bioavailability as it undergoes extensive first pass metabolism and low elimination half-life. The present study was aimed at studying sustained release behaviour of t...

Full description

Bibliographic Details
Main Authors: D D Vohra, K S Pagi, K S Rajesh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2012;volume=4;issue=5;spage=79;epage=80;aulast=Vohra
id doaj-6dc3fc6d7f7642dbb07d1373866a5477
record_format Article
spelling doaj-6dc3fc6d7f7642dbb07d1373866a54772020-11-24T23:24:50ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74060976-48792012-01-0145798010.4103/0975-7406.94147Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviourD D VohraK S PagiK S RajeshLosartan potassium is an angiotensin II receptor antagonist readily absorbed from the GIT, following oral administration. It has low bioavailability as it undergoes extensive first pass metabolism and low elimination half-life. The present study was aimed at studying sustained release behaviour of the drug using hydrophilic and hydrophobic polymers and to optimise using a 32 full factorial design. Eudragit and HPMC were used to evaluate the effect of hydrophilic and hydrophobic polymers on the release pattern of the drug. A full factorial was implemented at 20, 30 and 40% concentration of hydrophilic polymer and 2.5, 5 and 7.5% of hydrophobic polymer correlating with the release behaviour. Process variables were investigated and the results showed excellent adaptability in releasing drug over prolonged periods. Based on the results, it was found suitable to formulate a dosage form using optimum concentration of hydrophobic polymer along with hydrophilic polymer to vary the release behaviour for over 12 hours.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2012;volume=4;issue=5;spage=79;epage=80;aulast=VohraL0 osartan potassiummatrix tabletshydrophilic and hydrophobic polymers
collection DOAJ
language English
format Article
sources DOAJ
author D D Vohra
K S Pagi
K S Rajesh
spellingShingle D D Vohra
K S Pagi
K S Rajesh
Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
Journal of Pharmacy and Bioallied Sciences
L0 osartan potassium
matrix tablets
hydrophilic and hydrophobic polymers
author_facet D D Vohra
K S Pagi
K S Rajesh
author_sort D D Vohra
title Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
title_short Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
title_full Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
title_fullStr Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
title_full_unstemmed Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour
title_sort losartan potassium loaded sustained release matrix tablets: influence of various hydrophilic and hydrophobic polymers on drug release behaviour
publisher Wolters Kluwer Medknow Publications
series Journal of Pharmacy and Bioallied Sciences
issn 0975-7406
0976-4879
publishDate 2012-01-01
description Losartan potassium is an angiotensin II receptor antagonist readily absorbed from the GIT, following oral administration. It has low bioavailability as it undergoes extensive first pass metabolism and low elimination half-life. The present study was aimed at studying sustained release behaviour of the drug using hydrophilic and hydrophobic polymers and to optimise using a 32 full factorial design. Eudragit and HPMC were used to evaluate the effect of hydrophilic and hydrophobic polymers on the release pattern of the drug. A full factorial was implemented at 20, 30 and 40% concentration of hydrophilic polymer and 2.5, 5 and 7.5% of hydrophobic polymer correlating with the release behaviour. Process variables were investigated and the results showed excellent adaptability in releasing drug over prolonged periods. Based on the results, it was found suitable to formulate a dosage form using optimum concentration of hydrophobic polymer along with hydrophilic polymer to vary the release behaviour for over 12 hours.
topic L0 osartan potassium
matrix tablets
hydrophilic and hydrophobic polymers
url http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2012;volume=4;issue=5;spage=79;epage=80;aulast=Vohra
work_keys_str_mv AT ddvohra losartanpotassiumloadedsustainedreleasematrixtabletsinfluenceofvarioushydrophilicandhydrophobicpolymersondrugreleasebehaviour
AT kspagi losartanpotassiumloadedsustainedreleasematrixtabletsinfluenceofvarioushydrophilicandhydrophobicpolymersondrugreleasebehaviour
AT ksrajesh losartanpotassiumloadedsustainedreleasematrixtabletsinfluenceofvarioushydrophilicandhydrophobicpolymersondrugreleasebehaviour
_version_ 1725558584086888448